Seaview Investment Managers LLC X4 Pharmaceuticals, Inc Transaction History
Seaview Investment Managers LLC
- $403 Million
- Q1 2025
A detailed history of Seaview Investment Managers LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Seaview Investment Managers LLC holds 15,063 shares of XFOR stock, worth $43,983. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,063Holding current value
$43,983% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XFOR
# of Institutions
99Shares Held
97.9MCall Options Held
500KPut Options Held
20.4K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$49.4 Million1.36% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$43.8 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$31.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.07MShares$23.6 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY7.31MShares$21.3 Million1.22% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $200M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...